Chronic Lyme Disease: Patients Want Treatment, Not Just Management
PATIENTS WITH PERSISTENT SYMPTOMS OFTEN SEEK ANSWERS
MANY WANT TREATMENT AND RECOVERY
NOT ONLY LONG-TERM SYMPTOM MANAGEMENT
Chronic Lyme disease treatment remains one of the most debated topics in medicine. For many patients with persistent symptoms, the distinction between being “treated” and simply “managed” carries significant emotional and clinical weight.
The quote, “Minds are like parachutes. They only function when open,” attributed to Thomas Dewar, comes to mind when considering the ongoing debate surrounding chronic Lyme disease.
In an article published in the Infectious Disease Clinics of North America, the author argues that chronic, treatment-refractory Borrelia burgdorferi infection has not been convincingly demonstrated following standard therapy, citing the failure to detect cultivatable organisms after treatment.
The article further suggests that extended antibiotic therapy is not beneficial for most chronically symptomatic patients and that ongoing infection is unlikely in many cases.
A Shift From Treating to “Managing”
The article outlines a “clinical approach” to patients who believe they have chronic Lyme disease—an approach that emphasizes management rather than treatment.
Physicians are encouraged to:
- Listen patiently to patient concerns
- Review prior medical history and testing
- Explain why symptoms are not related to Lyme disease
Even when patients remain symptomatic, the framework suggests their illness may not be attributable to an active infection.
“Even if chronic Lyme disease lacks biological legitimacy, its importance as a phenomenon can be monumental to the individual patient.”
Patients, the author notes, are often frustrated after undergoing extensive medical evaluations without answers.
The Patient Experience
Patients with persistent symptoms are described as varying in their “commitment” to a chronic Lyme disease diagnosis—some firmly convinced, others uncertain.
Clinicians are advised to avoid appearing dismissive or rushed and to recognize that each patient’s story is valid, even if Lyme disease is ultimately ruled out.
While this approach emphasizes communication, it stops short of addressing the patient’s core concern: the need for effective treatment.
The Limits of Current Thinking
The article concludes that there is little evidence of active infection in chronically symptomatic patients and that antibiotics perform no better than placebo.
“Their symptoms do not respond to antibiotics any better than to placebo.”
However, this perspective may not fully account for the complexity of Lyme disease, including:
- Variable clinical presentations
- Limitations of current diagnostic testing
- Potential for persistent or difficult-to-detect infection
- The role of coinfections and host response
A one-size-fits-all framework may fail to capture the heterogeneity of Lyme disease.
The absence of definitive biomarkers for persistent symptoms does not necessarily resolve the underlying biological questions.
Treated vs Managed
For patients, the distinction is critical.
Management often means:
- Symptom monitoring without definitive intervention
- Reassurance without resolution
- Adaptation to ongoing illness
Treatment, in contrast, reflects an effort to:
- Identify underlying causes
- Address infection or contributing factors
- Improve function and quality of life
Many patients are seeking not only validation, but meaningful improvement in function and quality of life.
Clinical Perspective
When physicians enter the clinical encounter with fixed assumptions about Lyme disease, the risk is not only diagnostic error—but erosion of trust.
Effective care requires open inquiry, thorough evaluation, and a willingness to consider complex or evolving disease models.
Some patients may continue to experience symptoms because of immune dysfunction, coinfections, inflammation, autonomic dysfunction, or possibly persistent infection mechanisms that remain incompletely understood.
When clinicians are taught to “manage” rather than treat, the consequences extend beyond clinical outcomes.
They become ethical.
This dynamic—where patients are heard but not helped—is explored further in the ethics of Lyme disease diagnosis and treatment.
Clinical Takeaway
Chronic Lyme disease treatment remains controversial, but patients with persistent symptoms continue to seek meaningful evaluation and recovery.
Listening is important. But patients are also asking clinicians to remain open to investigating and addressing possible underlying causes of ongoing illness.
References
- Lantos PM. Infect Dis Clin North Am. 2015.
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention
